Friday, July 10, 2026

Drug profile · INN

iobenguane sulfate i-131

iobenguane sulfate i-131 (IOBENGUANE SULFATE I 131) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — iobenguane sulfate i-131
US status
approved
Class
Route
INJECTION
Patents
0
Programs
2
Data quality
0.84

Quick answer

iobenguane sulfate i-131 (IOBENGUANE SULFATE I 131) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN iobenguane sulfate i-131
Brand IOBENGUANE SULFATE I 131
Route INJECTION
Formulation INJECTABLE

Approval history

Authority Status Date
FDA approved

Pipeline programs

  1. IOBENGUANE (123I) , 68Ga-SSO120 Phase 2 · AXIM Biotechnologies · neuroblastoma
  2. PS22PET Phase 2 · AXIM Biotechnologies · (suspision on) Neuroblastoma

Frequently asked questions

What is iobenguane sulfate i-131?

iobenguane sulfate i-131 (IOBENGUANE SULFATE I 131) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for iobenguane sulfate i-131?

IOBENGUANE SULFATE I 131 is a marketed brand name for iobenguane sulfate i-131. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of iobenguane sulfate i-131?

iobenguane sulfate i-131 has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.